Imago BioSciences, Inc.
IMGODelisted Jan 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001623715
Imago BioSciences, Inc. was delisted on Jan 11, 2023; its insiders filed their last Form 4 on Jan 11, 2023; 106 institutions reported holding it in 13F filings for Q4 2022, worth $1.05B in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Imago BioSciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
IMGO is no longer listed, so this page shows Q4 2022. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 106
- +41 vs. Q3 2022
- Shares held
- 29.3M
- −2.46M (−7.7%) vs. Q3 2022
- Total value
- $1.05B
- +$575.7M (+120.4%) vs. Q3 2022
- New holders
- 56
- 25 more added
- Sold out
- 15
- 18 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMGO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 106 | $1.05B |
| Q3 2022 | 65 | $478.1M |
| Q2 2022 | 62 | $416.8M |
| Q1 2022 | 59 | $575.8M |
| Q4 2021 | 52 | $606.7M |
| Q3 2021 | 39 | $473.1M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Imago BioSciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Quantbot Technologies LP | 600 | $21.6K | 0.00% | −100−14.3% | Reduced |
| Citigroup Inc | 549 | $19.7K | 0.00% | −604−52.4% | Reduced |
| FMR LLC | 334 | $12.0K | 0.00% | −5,060,913−100.0% | Reduced |
| Belvedere Trading LLC | 268 | $9.63K | 0.01% | +268 | New |
| CWM, LLC | 15 | $1.00K | 0.00% | 00.0% | Unchanged |
| Ellevest, Inc. | 1 | $36 | 0.00% | +1 | New |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −2,471,313−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −1,885,112−100.0% | Sold out |
| Emerald Advisers, LLC | 0 | $0 | 0.00% | −853,637−100.0% | Sold out |
| Emerald Mutual Fund Advisers Trust | 0 | $0 | 0.00% | −699,960−100.0% | Sold out |
| Matrix Capital Management Company, LP | 0 | $0 | 0.00% | −361,000−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −343,846−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −189,193−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −178,567−100.0% | Sold out |
| Monarch Partners Asset Management LLC | 0 | $0 | 0.00% | −148,915−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −48,973−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −12,339−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −1,556−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −316−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −295−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −98−100.0% | Sold out |